Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2642270rdf:typepubmed:Citationlld:pubmed
pubmed-article:2642270lifeskim:mentionsumls-concept:C0597032lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0007595lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0431085lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C1533691lld:lifeskim
pubmed-article:2642270lifeskim:mentionsumls-concept:C0772162lld:lifeskim
pubmed-article:2642270pubmed:issue1lld:pubmed
pubmed-article:2642270pubmed:dateCreated1989-1-11lld:pubmed
pubmed-article:2642270pubmed:abstractTextAromatic polyamidines containing two, three or four benzamidine residues inhibit proteinase activity and proliferation of different human tumor cell lines, including leukemic (K562, HEL), melanoma (Colo 38) and B-lymphoid (WI-L2) cell lines. In addition, the benzamidine derivatives analysed in the present study inhibit cell growth of the Chinese hamster FHO6T1-1 cell line, obtained after transfection of primary lung cells with the activated human T24-Ha-ras-1 oncogene. After treatment of FHO6T1-1 cells with benzamidine derivatives, a sharp decrease of the content of Ha-ras-1 mRNA was found, but not of transferrin receptor mRNA. We found that inhibition of cell proliferation by tetra-benzamidine derivatives is not restricted to tumor cells, but concerns also non-tumorigenic cell lines as well as normal primary fibroblasts. Therefore, our analysis was extended to di- and tri-benzamidine derivatives, which could be proposed as useful substrates in the synthesis of drug-conjugated monoclonal antibodies or growth factors. The data obtained demonstrate that these latter compounds and their halo-derivatives also exhibit strong antiproliferative effects on in vitro cultured cells.lld:pubmed
pubmed-article:2642270pubmed:languageenglld:pubmed
pubmed-article:2642270pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:citationSubsetIMlld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2642270pubmed:statusMEDLINElld:pubmed
pubmed-article:2642270pubmed:issn0262-0898lld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:GuarneriMMlld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:GambariRRlld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:FerroniRRlld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:BarbieriRRlld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:FeriottoGGlld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:NastruzziCClld:pubmed
pubmed-article:2642270pubmed:authorpubmed-author:SpandidosDDlld:pubmed
pubmed-article:2642270pubmed:issnTypePrintlld:pubmed
pubmed-article:2642270pubmed:volume7lld:pubmed
pubmed-article:2642270pubmed:ownerNLMlld:pubmed
pubmed-article:2642270pubmed:authorsCompleteYlld:pubmed
pubmed-article:2642270pubmed:pagination25-39lld:pubmed
pubmed-article:2642270pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:meshHeadingpubmed-meshheading:2642270-...lld:pubmed
pubmed-article:2642270pubmed:articleTitleInhibition of 'in vitro' tumor cell growth by aromatic polyamidines exhibiting antiproteinase activity.lld:pubmed
pubmed-article:2642270pubmed:affiliationDipartimento di Scienze Farmaceutiche, Università di Ferrara, Italy.lld:pubmed
pubmed-article:2642270pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2642270pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed